Activision Blizzard (ATVI) Gets Ready for Overwatch - Jefferies
Get Alerts ATVI Hot Sheet
Rating Summary:
22 Buy, 22 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 27
Join SI Premium – FREE
Jefferies analyst, Brian Pitz, is positive on Activision Blizzard (NASDAQ: ATVI) after the company posted a solid beat in a relatively slow quarter that did not feature any AAA game launches. Non-GAAP revenue grew +29% Y/Y to $908MM, well above $800MM outlook and $813MM consensus. Non-GAAP EPS grew +44% Y/Y to $0.23, well above $0.11 outlook and $0.12 consensus. Of the $0.12 in Outperformance relative to guide, ~$0.07 was related to timing, about $0.03 was from strong franchise momentum and the earlier King close, and $0.02 was due to a 1x tax benefit. Guidance is ahead of Street: ATVI expects NG rev / EPS of $1.375B / $0.38 vs. Street $1.331B / $0.34.
Overwatch is launching May 24 and is the next big catalyst. Management says it will be Blizzard's biggest launch since Diablo in 2012 (12MM units in yr-1). We believe Destiny, which generated $500MM in day-one sales, is the better comp. Compared to Destiny, Overwatch will have an important high-margin PC SKU and the game should be a big eSports title.
The firm maintained a Buy rating and $45 price target. The stock is also a Jefferies' Franchise Pick.
For an analyst ratings summary and ratings history on Activision Blizzard click here. For more ratings news on Activision Blizzard click here.
Shares of Activision Blizzard closed at $34.91 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$231 at Bernstein SocGen
- Gartner (IT) PT Lowered to $164 at UBS on Q2 Outlook
- National Health Investors (NHI) PT Lowered to $81 at Truist Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
Jefferies & Co, Jefferies Franchise Pick ListSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share